Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV
Published March 15, 2017 · Recall initiated: January 19, 2017
Summary
FDA records drug Class II recall D-0492-2017, published March 15, 2017 and initiated January 19, 2017. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 37,445 bottles; Lot: a) 3078937 and 3078938 (NDC 0378-3545-93), exp August 2019 b) 3078937 (NDC 0378-3545-01), exp August 2019 c) 3078936 (0378-3545-05), exp August 2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle
What to do
Voluntary: Firm initiated · E-Mail
Get an email if MIRTAZAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIRTAZAPINE
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Nationwide
- UPC
- 0303783545936
- Lot
- a) 3078937 and 3078938 (NDC 0378-3545-93), exp August 2019 b) 3078937 (NDC 0378-3545-01), exp August 2019 c) 3078936 (0378-3545-05), exp August 2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton,April 22, 2020
- FDAMirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc.December 18, 2019
- FDAMirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc,March 15, 2017
- FDACalcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), RxMarch 15, 2017
- FDATriForce Peripheral Crossing Set, Individual product is packaged in a Tyvek-film sterilizable outer pouch. TheMarch 8, 2017
- FDAMicropuncture Check-Flo Performer Introducer Set, Individual product is packaged in a Tyvek-film sterilizableMarch 8, 2017
Questions about this recall
Was Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV recalled?
Yes. FDA published recall D-0492-2017 on March 15, 2017. Reported hazard: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIRTAZAPINE. UPC: 0303783545936.